Overview

Vasopressin Injection Versus Misoprostol During Hysteroscopic Myomectomy In Reducing Blood Loss And Operation Time.

Status:
Completed
Trial end date:
2017-03-15
Target enrollment:
Participant gender:
Summary
A prospective randomized study designed to compare the efficacy of transcervical vasopressin injection versus vaginal misoprostol in reducing intra -operative blood loss during hysteroscopic mymectomy .
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Zagazig University
Treatments:
Arginine Vasopressin
Misoprostol
Vasopressins